| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |